✦ LIBER ✦

The first case of Philadelphia chromosome-negative acute promyelocytic leukemia following imatinib for chronic myelogenous leukemia

✍ Scribed by Jad J. Wakim; Carlos A. Tirado; Jonathan Dowell; Weina Chen

Book ID: 116332659
Publisher: Elsevier
Year: 2012
Tongue: English
Weight: 459 KB
Volume: 205
Category: Article
ISSN: 2210-7762
DOI: 10.1016/j.cancergen.2012.01.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Philadelphia-negative acute myeloid leuk

Philadelphia-negative acute myeloid leukemia with new chromosomal abnormalities developing after first-line imatinib treatment for chronic phase chronic myeloid leukemia

✍ Carmen Fava; Jorge Cortes 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 306 KB 👁 2 views

## Induction of integrin b 1 expression in bone marrow cells after chemotherapy correlates with the overexpression of lung resistance protein and poor outcome in patients with multiple myeloma To the Editor: Acquired drug resistance continues to be one of the major obstacles hindering the successf

Novel chromosomal aberrations in Philade

Novel chromosomal aberrations in Philadelphia negative cells of chronic myelogenous leukemia patients on imatinib: report of three cases

✍ Athanasiadou, A; Stavroyianni, N; Saloum, R; Asteriou, O; Anagnostopoulos, A; Fa 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 81 KB

Philadelphia chromosome-negative chronic

Philadelphia chromosome-negative chronic myelogenous leukemia with rearrangement of the breakpoint cluster region. Long term follow-up results

✍ Jorge E. Cortes; Moshe Talpaz; Miloslav Beran; Susan M. O'Brien; Mary B. Rios; S 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 594 KB

Background. Five to 10% of patients with chronic myelogenous leukemia (CML) do not have the Philadelphia chromosome (Ph), but one-third of them have rearrangements of the breakpoint cluster region (BCR-positive). Methods. The authors analyzed the characteristics, treatment response, and prognosis o

Clonal chromosomal abnormalities in the

Clonal chromosomal abnormalities in the Philadelphia chromosome negative cells of chronic myeloid leukemia patients treated with imatinib

✍ Guilbert-Douet, N; Morel, F; Bris, M-J Le; Berthou, C; Morice, P; Bourquard, P; 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 83 KB

Effects of age on prognosis with imatini

Effects of age on prognosis with imatinib mesylate therapy for patients with Philadelphia chromosome-positive chronic myelogenous leukemia

✍ Jorge Cortes; Moshe Talpaz; Susan O'Brien; Francis Giles; Mary Beth Rios; Jianqu 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 1 views

## Abstract ## BACKGROUND Older age is a consistent poor prognostic factor in patients with Philadelphia chromosome (Ph)‐positive chronic myelogenous leukemia (CML). Whether this is related to an intrinsic worse disease biology or to inadequate drug delivery or excessive treatment‐associated toxic

Confirming evidence for the clonal devel

Confirming evidence for the clonal development and stem cell origin of philadelphia chromosome-negative chronic myelogenous leukemia

✍ Frederic J. Kaye; Vesna Najfeld; Jack Singer; Janet Cuttner; Philip J. Fialkow 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB 👁 2 views